Effect of aclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients

被引：7
|
作者：
Ciancio, G [1 ]
Burke, GW [1 ]
Suzart, K [1 ]
Mattiazzi, A [1 ]
Rosen, A [1 ]
Zilleruello, G [1 ]
Abitbol, C [1 ]
Montane, B [1 ]
Miller, J [1 ]
机构：
[1] Univ Miami, Sch Med, Dept Surg, Div Transplantat, Miami, FL 33136 USA
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(02)03131-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1944 / 1945
页数：2
相关论文
共 50 条
  • [31] Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil
    Magee, CC
    Halligan, RD
    Milford, EL
    Sayegh, MH
    [J]. CLINICAL NEPHROLOGY, 1999, 52 (01) : 44 - 46
  • [32] Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
    Lobritto, Steven J.
    Rosenthal, Philip
    Bouw, Rene
    Leung, Mimi
    Snell, Paul
    Mamelok, Richard D.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (11) : 1570 - 1575
  • [33] Conversion from azathioprina to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection
    Ferraris, JR
    Tambutti, ML
    Redal, MA
    Bustos, D
    Ramirez, JA
    Prigoshin, N
    [J]. TRANSPLANTATION, 2000, 70 (02) : 297 - 301
  • [34] Adverse effects (AE) of mycophenolate mofetil (MM) in pediatric renal transplant recipients (PRTx).
    Butani, L
    Palmer, J
    Polinsky, M
    Baluarte, HJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3302 - A3302
  • [35] Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection
    Butani, L
    Palmer, J
    Baluarte, HJ
    Polinsky, MS
    [J]. TRANSPLANTATION, 1999, 68 (01) : 83 - 86
  • [36] PHARMACOKINETICS OF MYCOPHENOLIC ACID IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS RECEIVING ORAL MYCOPHENOLATE MOFETIL
    Jacobs, Bart
    Cornelissen, Marlies
    Aarnoutse, Rob
    Schreuder, Michiel
    Bruggemann, Roger
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) : 829 - 829
  • [37] Clinically "silent" weight loss associated with mycophenolate mofetil in pediatric renal transplant recipients
    Laskin, Benjamin
    Goebel, Jens
    [J]. PEDIATRIC TRANSPLANTATION, 2008, 12 (01) : 113 - 116
  • [38] Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone
    ter Meulen, CG
    Gregoor, PJHS
    Weimar, W
    Hilbrands, LB
    [J]. TRANSPLANT INTERNATIONAL, 2001, 14 (02) : 99 - 102
  • [39] Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients
    Squifflet, JP
    Bäckman, L
    Claesson, K
    Dietl, KH
    Ekberg, H
    Forsythe, JLR
    Kunzendorf, U
    Heemann, U
    Land, W
    Morales, JM
    Mühlbacher, F
    Talbot, D
    Taube, D
    Tyden, G
    van Hooff, J
    Schleibner, S
    Vanrenterghem, Y
    [J]. TRANSPLANTATION, 2001, 72 (01) : 63 - 69
  • [40] Cyclosporine-sparing effect of basiliximab in renal transplant recipients with mycophenolate mofetil
    Tojimbara, T
    Sato, S
    Koyama, I
    Nanmoku, K
    Sekijima, M
    Tonsyo, M
    Kai, K
    Kato, Y
    Urashima, Y
    Nakajima, I
    Fuchinoue, S
    Teraoka, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 895 - 898
12345